Skip to main content

A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)

Active, not recruiting · Phase 3 · NCT03006068

Conditions: Ulcerative Colitis (UC)

At a glance

Research payments reported, 2025
$562,657
U.S. investigators named
45
Sites paid
46
Planned or actual enrollment
950

About the trial

Sponsor
AbbVie
Tested
Upadacitinib (ABT-494) (drug), Placebo (drug)
Dates
Started 2017-01-31; completion 2027-07
Results posted
Not yet

This study is designed to evaluate the long-term safety and efficacy of Upadacitinib in participants with ulcerative colitis (UC) who have not responded at the end of the induction period in Study M14-234 Substudy 1, who have had loss of response during the maintenance period of Study M14-234 Substudy 3, or who have successfully completed Study M14-234 Substudy 3.

From ClinicalTrials.gov, last updated 2026-01-12. Full record, eligibility and contacts (opens in a new tab)

Industry funding

AbbVie Inc. reported $562,657 in research payments for this study in 2025 (205 payments).

Products named: Rinvoq

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Mayo Clinic Rochester $38,852
  • Las Vegas Medical Research LLC $37,586
  • Cb Flock Research Corporation $35,740
  • Tyler Research Institute LLC $29,535
  • UC Healthcare System $25,633
  • Nature Coast Clinical Research $25,383
  • West Coast Clinical Trials LLC $24,605
  • Louisiana Research Center LLC $22,262
  • Temecula Valley Digestive Disease Consultants Amc DBA United Gastroenterologists $21,014
  • Fomat Medical Research $20,502
  • Optimed Research LTD $18,945
  • Donald Guthrie Foundation for Educa $18,213
  • Southern Star Research Institute LLC $16,824
  • Washington Univ in St Louis $14,483
  • Wisconsin Center for Advanced Research $13,573
  • Medical Research Center of Connecticut $11,631
  • Gastroenterology Associates PA $11,245
  • Cfagi LLC $11,052
  • Cotton O Neil Clinic Revocable Trust DBA Cotton O Neil Clinical Research Center Digestive Health; A $10,948
  • Universidad De Pr-Esc Farmacia $10,673
  • Gastroenterology Associates of Central Georgia LLC $9,678
  • Topography Health Inc $9,564
  • Benaroya Research Institute $9,279
  • Vilo Research Group Inc $9,050
  • Plains Clinical Research Center LLC $9,046
  • Carle Foundation Hospital, IL $8,983
  • Medical Associates Research Group $8,978
  • Encore Borland-Groover Clinical Research LLC $8,913
  • Endoscopic Research Inc $8,341
  • Rochester Gastroenterology $8,277
  • Texas Clinical Research Institute L $8,117
  • The Vancouver Clinic Inc Ps $6,485
  • Gastroenterology Center Of $5,538
  • Digestive Disease Specialists Inc $5,241
  • Wake Forest University $4,544
  • Carolinas Medical Center-Northeast, NC $4,282
  • Gcga Physicians Inc $4,000
  • University of Michigan Health System, MI $3,900
  • Digestive Health Associates of Texas PA $3,873
  • Next Innovative Cinical Research $3,000
  • Cooper University Hospital, NJ $1,284
  • Clinical Research Institute of Michigan LLC $1,229
  • Infinite Clinical Trials $839
  • Biomedical Research Alliance of New York $659
  • Options Health Research LLC $428
  • Ny Scientific Corp $428

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.